Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIRAFLAME Trial
NCT03449654Phase 4Completed
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Oct 2017
- Primary completion
- Aug 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Steno Diabetes Center Copenhagen. Started Oct 2017; status: completed.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03449654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03449654.